<DOC>
	<DOCNO>NCT00095823</DOCNO>
	<brief_summary>This trial 14 week , randomize , double-blind , placebo control study , assess safety efficacy aripiprazole adjunctive treatment ongoing antidepressant treatment patient Major Depressive Disorder .</brief_summary>
	<brief_title>A Study Adjunctive Aripiprazole Patients With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Men woman , 1865 year old Experienced Major Depressive Disorder current episode minimally 8 week duration . Treatment history inadequate response least one three antidepressant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>